The rates of prevalence for hypertension, diabetes mellitus, dyslipidemia, renal failure, cardiovascular disease, heart failure, and cerebrovascular disease was 34.8%, 15.9%, 41.7%, 3.3%, 3.5%, 4.3%, and 2.9%, respectively, while the rates of prescription for losartan, fenofibrate, SGLT2 inhibitors, diuretics, beta-blockers, and NSAIDs were 0.7%, 0.4%, 1.5%, 3.0%, 3.5%, and 8.1%, respectively. The gene discussed is SLC5A2; the disease is metabolic syndrome.